Although PER1 expression changes may indicated a functional change in the APP-PS1 circadian system, the minimal change in CK1δ expression in the APP-PS1 brain suggests that this is not due to the elevation of CK1 seen in the human AD brain. This evidence concerns the gene PER1 and Alzheimer disease.